Navigation Links
Dwaine Rieves, MD, Anthony Di Santo, PhD and Joachim Vollmar, MSc Join NDA Partners as Premier Expert Consultants
Date:7/25/2013

Madison, VA (PRWEB) July 25, 2013

Carl Peck, MD, Chairman of NDA Partners LLC (NDAP) (http://ndapartners.com/consultants/index.php?cat=partners&page=peck), today announced the addition of three senior industry executives to its roster of Premier Expert consultants. NDA Partners Premier Experts are top tier consultants whose expertise and professional stature enable them to bring extraordinary value to the company’s clients. Premier Experts collaborate to design and implement critical solutions to help clients successfully develop their medical products, pursue optimal regulatory pathways, build a company that is attractive to professional investors, and initiate access to global markets.

Dwaine Rieves, MD, FCCP – Dr Rieves is an expert in drug and biological product development, diagnostic imaging drug development, regulatory strategies, and the medical subspecialties of hematology, critical care medicine, radiation medical countermeasures and pulmonary medicine. Dr Rieves has extensive experience within the US Food & Drug Administration (FDA) including Director, Division of Medical Imaging Products (CDER) (http://www.fda.gov/AboutFDA/CentersOffices/.../CDER/ucm239012.htm), Director, Division of Medical Imaging and Hematology Products (CDER), and Chief, Clinical Trials Branch, Division of Clinical Trials and Analysis, Office of Cellular and Gene Therapy (CBER).

Anthony Di Santo, PhD - Dr Di Santo is an expert in bioavailability/pharmacokinetic studies to meet regulatory requirements in the development of NCE’s from IND onward. His scope of expertise includes early interaction with marketing research to implementing the manufacture of bulk drug for preclinical pharmacology, toxicology and formulation development, up to the contracting of phase I/II clinical studies. He has extensive industry experience including positions as Vice President, Worldwide Drug Delivery Research & Development for the Upjohn Company and interim senior operations roles in several mid-size biopharmaceutical companies.

Joachim Vollmar, MSc – Mr Vollamr is an internationally recognized biostatistician and a co-founder of PRESCOS, an AAALAC accredited contract preclinical research lab. He was previously Executive Vice President of Global Product Development Services and Managing Director of European Operations for PRA International, where he was a company co-founder. Prior to PRA Mr Vollmar served as Head of the Department of Risk Analysis Therapeutics at Boehringer Mannheim (Mannheim, Germany). He was Co-Chair of the DIA Statistics SIAC, a Member of the Commission “Coordination Centers of Clinical Trials” of the German Federal Ministry of Education and Research (BMFT Gutachterausschuss “Koordinierungszentren für klinische Studien” (KKS)), and a Member of Commission B4 (Endocrinology) of the Federal Agency of Public Health (BGA) in Berlin, Germany.

“Our new Premier Experts further strengthen our international roster of highly-experienced medical product development experts and will play a key role in the delivery of high-impact services to our clients”, said Dr Peck. “These individuals represent some of the very best in their fields of expertise and we are pleased with their decision to become part of the NDA Partners team.”

About NDA Partners
NDAP is a strategy consulting firm specializing in expert product development and regulatory advice to the medical products industry and associated service industries such as law firms and investment funds. The highly experienced Principals and Premier Experts of NDA Partners include two former FDA Center Directors and an extensive international team of former pharmaceutical and medical device industry senior executives and regulators. Services include expert consulting, product development planning, regulatory strategy, advisory boards, product assessments and due diligence, litigation and patent support, and associated support projects.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10962818.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Olympic Champion and Health and Fitness Advocate Dara Torres Partners with Vestiage
2. First 3D Complex Cataract Surgery Performed in Canada at Trillium Health Partners
3. Plasan Carbon Composites Partners With Toray Industries To Strengthen Material and Technology Capabilities
4. QIAGEN Partners with Exosome Diagnostics to Create High-Performance Biofluid Sample Preparation Kits for Personalized Healthcare Research
5. Centius – Partners with Engaged Nation– a Leading Gaming Industry Customer Loyalty Solution Provider to Help Maximize Customer Lifetime Value
6. BioSpecifics Technologies Corp. Announces Partnership between Auxilium and Swedish Orphan Biovitrum AB for XIAPEX in Eurasia and Africa
7. Schrödinger and ChemAxon Extend Partnership
8. Medical University of South Carolina Partners with iLab Solutions to Streamline Core Facility Operations, Boost Efficiency and Save Money
9. BioLife Solutions Announces Strategic Partnership with HemaCare
10. Inflamax Research Inc. Enters Strategic Partnership with Northern Air Environmental Technologies Inc.
11. Used Scientific Equipment Supplier, BMI Surplus, Partners with Universities During Sequester
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... WonderWorks, ... NASA to showcase the future of deep space exploration and inspire space enthusiasts. ... Orion spacecraft and includes a guest appearance by former Shuttle Astronaut Don Thomas. ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... headlines and drive high-level conversations among healthcare industry stakeholders, the discussion surrounding the ... – taking place May 15-18, 2017 in Los Angeles, Calif. Hosted by the ...
(Date:4/25/2017)... April 25, 2017 Providence ... licensed its novel immune-modulating technology to an undisclosed global ... allergy. Tregitopes, pronounced T·rej·itopes, are a ... by EpiVax CEO Annie De Groot ... immunoglobulin G, an autoimmune disease therapy, Tregitopes are ...
(Date:4/24/2017)... NEW YORK , April 24, 2017  Dante Labs ... interpretation at only EUR 850 (ca. $900). While American individuals ... marks the first time Europeans can access WGS below EUR ... which are crucial to leveraging genetic information to make informed ... more. ...
Breaking Biology Technology:
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... - Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle ... around 15.1% over the next decade to reach approximately $1,580 million ... estimates and forecasts for all the given segments on global as ...
Breaking Biology News(10 mins):